Measuring Pharyngeal Muscle Improvements Following Behavioral Swallowing Exercises

February 22, 2023 updated by: NYU Langone Health
The purpose of this study is to learn more about how exercise and protein supply affect swallow muscles. Twenty healthy older adults will be recruited from local community centers, physician offices, and retirement communities via flyers. Participants will complete 16 sessions of standard of care swallowing exercises 2 times per week for 8 weeks. All sessions will be conducted via Zoom. During each session, a series of swallow exercises will be performed following a demonstration from a trained speech-language pathologist. Participants will be referred to NYU Langone Health or White Plains Hospital, for a videofluoroscopic swallowing study, acoustic pharyngometry and measures of hand grip strength before and after the treatment protocol. Patients will be able to select their preferred site for swallow study completion. Results will inform the relationship between swallow exercises and pharyngeal muscles. All devices and exercises are established as safe and effective and are FDA approved.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The natural next step in this program of research is to investigate interventions for reversing pharyngeal sarcopenia with the ultimate goal of developing novel therapeutic strategies to address this pervasive clinical issue. The exercise science literature suggests that sarcopenia in the limb muscles can be reversed through a combination of rigorous exercise and adequate levels of dietary protein. The innovative multi-disciplinary protocol, PEPP (Pharyngeal Exercises Plus Protein), combines pharyngeal swallowing exercises selected for their known activation of the pharyngeal muscles with daily supplemental protein drinks. The research lab had documented successful improvements to swallowing physiology and pharyngeal sarcopenia in a pilot series of 5 older women using PEPP. However the research was abruptly halted due to both ethical and feasibility challenges posed by the COVID-19 pandemic. In response to these challenges, this study is seeking to establish the feasibility and effectiveness when the PEPP intervention is delivered using telehealth (telePEPP).

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10016
        • NYU Langone Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 120 years (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 65 and older
  • SARC-F score of ≥4
  • Functional hearing and vision status
  • Access to reliable internet connection
  • Availability of caregiver/family support and/or comfort with independent technology usage

Exclusion Criteria:

  • Known structural or neurological causes of dysphagia
  • Not suitable to consume high levels of protein supplementation (i.e. moderate to severe kidney dysfunction)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Generalized sarcopenia group
Older adults will be recruited from local community centers, physician offices, and retirement communities via flyers. Participants will complete 16 sessions of standard of care swallowing exercises 2 times per week for 8 weeks. All sessions will be conducted via Webex. During each session, a series of standard of care swallow exercises will be performed following a demonstration from a trained speech-language pathologist.
TelePEPP sessions will be conducted twice per week by a Speech Language Pathologist and/or graduate student clinician, on the study team. This clinician will deliver the intervention from the NYU Voice Center using the web conferencing software Webex (institutional license) on a Dell desktop computer with a 3.1 GHz intel core processor and high definition camera. Each exercise set will include 40 repetitions (10 reps of effortful swallows, tongue hold swallows, effortful pitch glides and maximal posterior tongue presses). All exercises are widely-adopted by clinicians as standard of care exercises. The number of sets will be gradually increased as tolerance builds [2 sets in week 1, 3 sets in week 2, 4 sets in weeks 3+].

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of pharyngeal constriction before intervention
Time Frame: Session 0 (Day 0 pre-intervention visit)
2D lateral videofluoroscopic images will be used to measure pharyngeal constriction pre and post intervention
Session 0 (Day 0 pre-intervention visit)
Measurement of pharyngeal constriction after intervention
Time Frame: Session 17 (9 week post-intervention visit)
2D lateral videofluoroscopic images will be used to measure pharyngeal constriction pre and post intervention
Session 17 (9 week post-intervention visit)
Measurement of pharyngeal shortening before intervention
Time Frame: Session 0 (Day 0 pre-intervention visit)
2D lateral videofluoroscopic images will be used to measure pharyngeal shortening pre and post intervention
Session 0 (Day 0 pre-intervention visit)
Measurement of pharyngeal shortening after intervention
Time Frame: Session 17 (9 week post-intervention visit)
2D lateral videofluoroscopic images will be used to measure pharyngeal shortening pre and post intervention
Session 17 (9 week post-intervention visit)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of pharyngeal wall thickness before intervention
Time Frame: Session 0 (Day 0 pre-intervention visit)
2D lateral videofluoroscopic images will be used to measure wall thickness pre and post intervention
Session 0 (Day 0 pre-intervention visit)
Measurement of pharyngeal wall thickness after intervention
Time Frame: Session 17 (9 week post-intervention visit)
2D lateral videofluoroscopic images will be used to measure wall thickness pre and post intervention
Session 17 (9 week post-intervention visit)
Measurement of pharyngeal volume before intervention
Time Frame: Session 0 (Day 0 pre-intervention visit)
Acoustic Pharyngometry will be used to measure pharyngeal volume pre and post intervention.
Session 0 (Day 0 pre-intervention visit)
Measurement of pharyngeal volume after intervention
Time Frame: Session 17 (9 week post-intervention visit)
Acoustic Pharyngometry will be used to measure pharyngeal volume pre and post intervention.
Session 17 (9 week post-intervention visit)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sonja M Molfenter, PhD, CCC-SLP, NYU Langone Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2022

Primary Completion (Actual)

October 4, 2022

Study Completion (Actual)

October 4, 2022

Study Registration Dates

First Submitted

September 9, 2021

First Submitted That Met QC Criteria

October 4, 2021

First Posted (Actual)

October 18, 2021

Study Record Updates

Last Update Posted (Actual)

February 24, 2023

Last Update Submitted That Met QC Criteria

February 22, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This study is to collect a series of pilot data to support an NIH grant submission to test the intervention during a randomized control trial. If the application is successful, the IPD of the NIH funded RCT will be made sharable.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dysphagia

Clinical Trials on TelePEPP intervention

Subscribe